#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia Pemphigoid Ewing's sarcoma metastatic Neutropenia Scedosporium infection Primary myelofibrosis Thermal burn Transitional cell cancer of the renal pelvis and ureter Myasthenia gravis Huntington's disease Glomerulonephritis chronic Neuroendocrine carcinoma metastatic Squamous cell carcinoma of the cervix Thromboangiitis obliterans Anti-HLA antibody test positive More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Life with Disease Haemophilia – Life with Disease Osteosarcoma metastatic – Basic Information Mucopolysaccharidosis I – Diagnostics Ewing’s sarcoma recurrent – Treatment Antithrombin III deficiency Rhabdomyosarcoma recurrent – Basic Information Haemophagocytic lymphohistiocytosis – Life with Disease Lymphangiosarcoma Primary biliary cholangitis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Laronidase VORMATRIGINE Bms-986315 Teclistamab Trazodone Mitomycin Cenegermin Elasomeran Gefitinib VG801-2 Valaciclovir Elotuzumab 10-1074-Ls Specific Nucleic Acid Sna-Her1 Meropenem Trihydrate Taldefgrobep Alfa 18F-Fludarabine GSKVX000000034798 Buloxibutid Timbetasin Acetate More therapies…

    Learn about Your Condition

    Tonsillitis Congenital pseudarthrosis Anaemia of chronic disease Obstructive airways disorder Ewing's sarcoma metastatic Necrotising myositis Breast cancer metastatic Cerebral palsy Iron deficiency Anal incontinence Arthritis infective Prinzmetal angina Demyelination Inguinal hernia Optic glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Ticagrelor and Acetylsalicylic Acid in Patients with Coronary Artery Disease Undergoing CABG Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid Ph. Eur.
    • Acetylsalicylic Acid
    • Ticagrelor
    Austria Germany Sweden

  • Study on the Effectiveness of INCB000928 for Patients with Fibrodysplasia Ossificans Progressiva

    Recruiting

    2 1
    Investigated Diseases:
    • Fibrodysplasia ossificans progressiva
    Investigated Drugs:
    • Incb000928
    France Germany Italy The Netherlands Portugal Spain

  • Study on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Cisplatin
    France

  • Study on the Effects of (+)-α-Dihydrotetrabenazine for Patients with Moderate to Severe Tardive Dyskinesia

    Recruiting

    2 1
    Investigated Drugs:
    • (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol
    Czechia Hungary Poland Slovakia

  • Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Vinblastine Sulfate
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Finland France Germany +4

  • Safety Study of Mesenchymal Cells for Preterm Infants with Bronchopulmonary Dysplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Mesenchymal Cells
    Spain
Previous Page
1 … 380 381 382 383 384 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!